GA
PFE icon

Glenhill Advisors’s Pfizer PFE Stock Holding History

Glenhill Advisors’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-9,764
Closed -$298K – 116
2014
Q1 		$298K Buy
9,764
+3,994
+69% +$119K 0.03% 101
2013
Q4 		$168K Sell
5,770
-140,047
-96% -$4.08M 0.02% 103
2013
Q3 		$3.97M Buy
+145,817
New +$3.97M 0.39% 64

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Glenhill Advisors's PFE Position: Q2 2014 in Review

Glenhill Advisors sold out of Pfizer (PFE) in Q2 2014, closing a stake of 9,764 shares — an estimated $298K sold.

Glenhill Advisors first reported a position in PFE in Q3 2013 and held it in 3 quarters. The position peaked at $3.97M in Q3 2013. 1,746 funds tracked by Wall St. Rank hold PFE as of Q2 2014.

  • Glenhill Advisors reported no remaining Pfizer position as of Q2 2014 after selling out during the quarter.
  • Glenhill Advisors sold 9,764 Pfizer shares in Q2 2014, an estimated $298K.
  • Glenhill Advisors first reported a position in Pfizer in Q3 2013 and held it in 3 quarters.
  • Glenhill Advisors's Pfizer position peaked at $3.97M in Q3 2013.
  • 1,746 funds tracked by Wall St. Rank held Pfizer as of Q2 2014.

Based on Glenhill Advisors's 13F filing for Q2 2014, filed 14 Aug 2014.